The Pharma Data

AUGUST 27, 2020

Moderna has announced that its coronavirus vaccine candidate has shown promise in generating an immune response in elderly patients in an early-stage clinical trial. . Each patient was given two 100 microgram doses of the vaccine 28 days apart. There is hope that Moderna’s vaccine could be available by early 2021. .

Vaccine 90

Vaccine Immune Response Clinical Trials Virus 90

The Pharma Data

DECEMBER 19, 2020

government’s public-private partnership to deliver COVID-19 vaccines to Americans, and under the direction of the Centers for Disease Control and Prevention (CDC) , McKesson began distributing Moderna’s COVID-19 vaccines and the ancillary supply kits needed to administer them. government. Photo: Business Wire).

Government 52

Government Vaccine Pharmacy Pharmaceuticals 52

The Pharma Data

AUGUST 31, 2020

Johnson & Johnson Announces Agreement in Principle with Government of Canada to Supply its COVID-19 Vaccine Candidate. Johnson & Johnson Announces Agreement in Principle with Government of Canada to Supply its COVID-19 Vaccine Candidate. S vaccine candidate on a not-for-profit basis for emergency pandemic use.

Government 52

Government Vaccine Pharmaceutical Companies Clinical Trials 52

Eye on FDA

SEPTEMBER 10, 2020

Vaccines for COVID-19 are the focus of the moment – politically and scientifically speaking. Scientifically, there was the big news that a vaccine trial had experienced a serious adverse event bringing a pause to bear in its continuation, likely throwing further cold water on the political side of the equation.

Vaccine 82

Vaccine Research Government Science 82

The Pharma Data

AUGUST 14, 2020

The UK Government has signed a new deal with Johnson & Johnson and Novavax to secure 90 million orders of their vaccine candidates to protect against COVID-19 infection. . S, the COVID-19 vaccine candidate developed by Janssen, the pharmaceutical subsidiary of J&J, for not-for-profit emergency pandemic use.

Government 52

Government Vaccine Clinical Trials Therapies 52

The Pharma Data

AUGUST 5, 2020

Government for 100 Million Doses of Investigational COVID-19 Vaccine. Government for 100 Million Doses of Investigational COVID-19 Vaccine. Company working to ensure broad global access to COVID-19 vaccine candidate, following approval from regulators. Johnson & Johnson Announces Agreement with U.S.

Government 52

Government Vaccine Pharmaceutical Companies Pharmaceuticals 52

The Pharma Data

JULY 23, 2021

government has purchased an additional 200 million doses of the Pfizer-BioNTech COVID-19 Vaccine. government under its existing supply agreement to 500 million. government with 500 million doses of the companies’ COVID-19 vaccine for donation to the world’s poorest nations. This press release features multimedia.

Vaccine 52

Vaccine Government Immune Response FDA 52

The Pharma Data

OCTOBER 28, 2021

GOVERNMENT AN Fresh 50 MILLION PEDIATRIC Boluses OF COVID-19 VACCINE TO SUPPORT Farther PREPAREDNESS FOR FUTURE NEEDS. government has bought 50 million further boluses of the companies’COVID-19 vaccine. government has exercised its final purchase option under its beingU.S. PFIZER AND BIONTECH TO GiveU.S.

Government 52

Government Vaccine Clinical Trials FDA 52

The Pharma Data

OCTOBER 21, 2020

More than two dozen researchers and experts have penned a letter to HHS Secretary Alex Azar, National Institutes of Health (NIH) officials and pharma company executives, imploring them to shed more light on the clinical trial designs for federally funded COVID-19 vaccine studies. Source link.

Vaccine 52

Vaccine Government Trials Pharma Companies 52

The Pharma Data

AUGUST 13, 2020

The UK government has signed deals for a further 90 million doses of coronavirus vaccine. The vaccines are being developed by the Belgian pharmaceutical company Janssen and the US biotech company Novavax. It means the UK has placed orders for six experimental vaccines, taking its potential stockpile to 340 million doses.

Vaccine 52

Vaccine Virus Government Clinical Trials 52

The Pharma Data

JUNE 25, 2021

Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the U.S. government has purchased an additional 200 million doses of Moderna’s COVID-19 vaccine, including the option to purchase other COVID-19 vaccine candidates from Moderna’s pipeline.

Government 40

Government Vaccine RNA Science 40

The Pharma Data

SEPTEMBER 25, 2020

A trial of a new vaccine that appears to train the immune system to fight coronavirus has begun in the UK. The trial on 10,000 people will now see if the vaccine can prevent people getting ill. The UK government has already ordered 60 million doses in case it proves successful. Image copyright. Image caption.

Vaccine 52

Vaccine Trials Immune Response Virus 52

The Pharma Data

DECEMBER 16, 2020

(Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced an Advance Purchase Agreement with the government of New Zealand for the purchase of 10.7 million doses of NVX-CoV2373, Novavax’ candidate vaccine against COVID-19. About NVX-CoV2373.

Vaccine 52

Vaccine Government Immune Response Clinical Trials 52

The Pharma Data

AUGUST 12, 2020

Moderna continues to rise to meet the demands of the pandemic, signing a new deal with the US Government to supply 100 million doses of its messenger RNA (mRNA) vaccine candidate for the prevention of COVID-19. billion in total to the research and delivery of the vaccine candidate under its Operation Warp Speed. Matt Fellows.

Vaccine 52

Vaccine Government RNA Clinical Trials 52

The Pharma Data

DECEMBER 17, 2020

Advisory Committee Votes to Recommend EUA for Moderna Vaccine. 17, 2020 — The Moderna COVID-19 vaccine received recommendation from a U.S. Food and Drug Administration advisory committee on Thursday, clearing the way for it to become the second COVID-19 vaccine to be granted emergency use authorization. THURSDAY, Dec.

Vaccine 52

Vaccine Clinical Trials Government FDA 52

The Pharma Data

AUGUST 5, 2020

Company working to ensure broad global access to COVID-19 vaccine candidate, following approval from regulators. government for the large scale domestic manufacturing and delivery in the U.S. of 100 million doses of Janssen’s SARS-CoV-2 investigational vaccine, Ad26.COV2.S, NEW BRUNSWICK, N.J., NEW BRUNSWICK, N.J.,

Government 40

Government Vaccine Pharmaceutical Companies Pharmaceuticals 40

The Pharma Data

APRIL 4, 2021

Johnson & Johnson is assuming full responsibility regarding the manufacturing of drug substance for its COVID-19 vaccine at the Emergent BioSolutions Inc. Additional information: All Johnson & Johnson COVID-19 vaccine doses distributed to date have met rigorous Company and regulatory quality standards. Bayview facility.

Vaccine 52

Vaccine Government Drugs 52

The Pharma Data

AUGUST 14, 2020

Parents are being urged to make sure their children are up-to-date with all their routine vaccinations. The Local Government Association said high vaccine uptake could prevent infections and stop pressure being piled on the NHS. Vaccines protect children against serious diseases including measles, meningitis and whooping cough.

Vaccine 52

Vaccine Government Disease Research 52

The Pharma Data

DECEMBER 18, 2020

Indigenous Communities Start Receiving COVID-19 Vaccines. 18, 2020 — Indigenous communities in the United States have started receiving COVID-19 vaccines from federal and state agencies. Other tribes will receive vaccine deliveries through state health agencies, the AP reported. FRIDAY, Dec.

Vaccine 52

Vaccine Government 52

The Pharma Data

NOVEMBER 19, 2020

Russia’s Gamaleya Research Institute has reportedly resumed dosing in a phase 3 trial evaluating its COVID-19 vaccine, Sputnik V., but a Russian government spokesperson denies that the study was ever paused. Source link.

Vaccine 52

Vaccine Trials Government Research 52

The Pharma Data

NOVEMBER 12, 2020

billion Operation Warp Speed vaccine contract in a Securities and Exchange Commission (SEC) filing this week, ending speculation about the details. Novavax published its entire $1.6 Source link.

Vaccine 40

Vaccine Government Research 40

The Pharma Data

DECEMBER 11, 2020

Hacker groups in Russia and North Korea continue to mount cyberattacks against companies working on COVID-19 vaccines and treatments, Microsoft warned, calling on governments to take action against them. Among the targets, the majority are vaccine makers that have COVID-19 vaccines in various stages of clinical trials.

Vaccine 52

Vaccine Drug Development Government Clinical Research 52

The Pharma Data

OCTOBER 26, 2020

26, 2020 — When scientists finish developing a COVID-19 vaccine, will people be willing to take it? An international research team analyzed data from 19 countries hit hard by the new coronavirus and found that when confidence in government was low, hesitancy to accept a COVID-19 vaccine was higher. MONDAY, Oct.

Vaccine 52

Vaccine Government International Trials 52

The Pharma Data

AUGUST 28, 2020

The government plans to train up an army of health professionals to be ready to give the coronavirus vaccine, if and when one is shown to work. This could include pharmacists, who already deliver flu vaccines, midwives and physiotherapists. But a vaccine is not expected to be ready before Christmas. Image copyright.

Vaccine 52

Vaccine Immune Response Nurses Government 52

The Pharma Data

NOVEMBER 10, 2020

Russia’s Gamaleya Center Research Institute claimed its investigational COVID-19 vaccine, Sputnik V, has demonstrated 92 percent efficacy in a late-stage trial. The finding was based on interim data from a phase 3 study, based on 20 confirmed cases of COVID-19, split across patients given the vaccine and patients given the placebo.

Vaccine 52

Vaccine Government Trials Research 52

The Pharma Data

NOVEMBER 22, 2021

Company Welcomes Leadership Shown by the European Commission and EU Member States, plus Norway and Iceland to Help Advance Equitable Access to Our Vaccine. As a practical rapid response to the urgent need to scale up equitable access to vaccines, these doses will be utilized to help protect individuals in lower-income countries.

Vaccine 52

Vaccine Government Treatment 52

The Pharma Data

NOVEMBER 23, 2020

As the Pfizer-BioNTech COVID-19 vaccine is being evaluated by the U.S. Food and Drug Administration (FDA) and the Moderna vaccine is soon to follow, here’s a look at several of the top COVID-19 vaccine candidates and where they stand as of today. The prices for the vaccines are moving targets, dependent upon the amount ordered.

Vaccine 52

Vaccine Virus Immune Response Trials 52

The Pharma Data

JANUARY 29, 2021

French vaccine company Valneva said it has begun production of its investigational COVID-19 vaccine, which is now in a phase 1/2 clinical trial in the UK. Valneva also plans to test the vaccine in more than 4,000 patients in additional trials.

Vaccine 52

Vaccine Production Clinical Trials Trials 52

The Pharma Data

SEPTEMBER 2, 2020

. Sanofi and GSK have begun a Phase I/II clinical trial testing their adjuvanted COVID-19 vaccine in healthy adults. The vaccine candidate, developed in partnership by the firms, is based on the recombinant protein-based technology used in Sanofi’s seasonal influenza vaccines and GSK’s pandemic adjuvant technology.

Vaccine 52

Vaccine Trials Immune Response Clinical Trials 52

The Pharma Data

OCTOBER 26, 2020

COVID-19 Vaccine Trials. 26, 2020 — Drugmakers AstraZeneca and Johnson & Johnson are ready to resume paused COVID-19 vaccine trials after health scares, CNN reported. Professional. AstraZeneca, J&J Resume U.S. MONDAY, Oct. CNN Article. © 2020 HealthDay. All rights reserved. Posted: October 2020.

Vaccine 52

Vaccine Trials Government Drugs 52

The Pharma Data

DECEMBER 30, 2020

Is First Country to Approve Oxford-AstraZeneca COVID-19 Vaccine. 30, 2020 — Britain became the first country to give authorization to the COVID-19 vaccine developed by AstraZeneca and the University of Oxford, The New York Times reported Wednesday. WEDNESDAY, Dec. The New York Times Article. © 2020 HealthDay. All rights reserved.

Vaccine 52

Vaccine Clinical Trials Government Regulations 52

The Pharma Data

DECEMBER 2, 2020

Britain Approves Emergency Use of Pfizer COVID-19 Vaccine. 2, 2020 — Britain became the first Western country to allow emergency use of a COVID-19 vaccine on Wednesday after approving the Pfizer vaccine candidate in the race to inoculate millions of people around the globe. WEDNESDAY, Dec. The New York Times Article.

Vaccine 52

Vaccine Long-Term Care Facilities Nurses Government 52

The Pharma Data

JANUARY 22, 2021

As research developments into RNA vaccines help scientists accelerate drug candidates to arm the immune system against coronavirus, Pharma IQ ’s Keeping tabs on Covid-19 update returns with news from some of the biotechnology innovators leading the fight against the global pandemic.

Vaccine 52

Vaccine Immune Response Government RNA 52

The Pharma Data

DECEMBER 20, 2020

UK drug developer Scancell said it has chosen a COVID-19 vaccine candidate, SN14, from more than a dozen potential products to advance to a clinical trial. . SN14 works by targeting the coronavirus’ nucleocapsid and spike proteins to prevent viral replication using the company’s ImmunoBody DNA vaccine technology.

Clinical Trials 52

Clinical Trials Vaccine Pharma Companies Trials 52

The Pharma Data

OCTOBER 20, 2020

No COVID-19 Vaccines Allowed in California Without State Approval. 20, 2020 — California is not going to allow the use of any COVID-19 vaccines until its own panel of experts approves them, Gov. The governor named 11 doctors and scientists who will review any vaccines approved by the federal government or vaccine developers.

Vaccine 52

Vaccine Doctors Government Disease 52

The Pharma Data

SEPTEMBER 10, 2020

Pascal Soriot, Chief Executive of AstraZeneca, said that the company’s vaccine could still be available this year, despite the clinical trials being paused after a participant became ill. . We could still have a vaccine by the end of this year, early next year.”. Photo by D Wells. Conor Kavanagh. Source link.

Vaccine 52

Vaccine Clinical Trials Trials Government 52

The Pharma Data

AUGUST 12, 2020

Mexico aims to conduct late stage trials for coronavirus vaccines designed by US and Chinese companies. This is in hope that these countries may base their vaccine production in Mexico. He also said specifically that the Chinese companies were interested in producing a vaccine for Mexico and the rest of the Latin American market.

Vaccine 52

Vaccine Trials Government Production 52